EE200000146A - Monoamiini oksüdaasi inhibiitori kombinatsioon h5-HT 1B antagonisti või osalise agonistiga - Google Patents

Monoamiini oksüdaasi inhibiitori kombinatsioon h5-HT 1B antagonisti või osalise agonistiga

Info

Publication number
EE200000146A
EE200000146A EEP200000146A EEP200000146A EE200000146A EE 200000146 A EE200000146 A EE 200000146A EE P200000146 A EEP200000146 A EE P200000146A EE P200000146 A EEP200000146 A EE P200000146A EE 200000146 A EE200000146 A EE 200000146A
Authority
EE
Estonia
Prior art keywords
combination
monoamine oxidase
partial agonist
oxidase inhibitor
ht1b antagonist
Prior art date
Application number
EEP200000146A
Other languages
English (en)
Estonian (et)
Inventor
Berg Stefan
Ross Svante
Thorberg Seth-Olov
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200000146A publication Critical patent/EE200000146A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
EEP200000146A 1997-09-18 1998-09-09 Monoamiini oksüdaasi inhibiitori kombinatsioon h5-HT 1B antagonisti või osalise agonistiga EE200000146A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9703376A SE9703376D0 (sv) 1997-09-18 1997-09-18 A new combination
PCT/SE1998/001602 WO1999013878A1 (en) 1997-09-18 1998-09-09 A COMBINATION OF A MONOAMINE OXIDASE INHIBITOR AND A h5-HT1B ANTAGONIST OR PARTIAL AGONIST

Publications (1)

Publication Number Publication Date
EE200000146A true EE200000146A (et) 2001-02-15

Family

ID=20408296

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000146A EE200000146A (et) 1997-09-18 1998-09-09 Monoamiini oksüdaasi inhibiitori kombinatsioon h5-HT 1B antagonisti või osalise agonistiga

Country Status (27)

Country Link
US (1) US6159970A (de)
EP (1) EP1014986B1 (de)
JP (1) JP2001516719A (de)
KR (2) KR20010024087A (de)
CN (1) CN1278727A (de)
AR (1) AR013503A1 (de)
AT (1) ATE270889T1 (de)
AU (1) AU752719B2 (de)
BR (1) BR9812236A (de)
CA (1) CA2302204A1 (de)
DE (1) DE69825062T2 (de)
DK (1) DK1014986T3 (de)
EE (1) EE200000146A (de)
ES (1) ES2222603T3 (de)
HU (1) HUP0100621A2 (de)
ID (1) ID25789A (de)
IL (1) IL134775A0 (de)
IS (1) IS5401A (de)
MX (1) MXPA00002616A (de)
NO (1) NO20001400L (de)
PL (1) PL339368A1 (de)
PT (1) PT1014986E (de)
SE (1) SE9703376D0 (de)
SK (1) SK2832000A3 (de)
TR (1) TR200000725T2 (de)
WO (1) WO1999013878A1 (de)
ZA (1) ZA987804B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957948A (en) * 1988-05-05 1990-09-18 Interface, Inc. Biocidal protective coating for heat exchanger coils
SE9601110D0 (sv) 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives
WO2002066454A1 (en) * 2001-02-21 2002-08-29 Sankyo Company, Limited Chromene derivatives
US7504395B2 (en) * 2001-07-20 2009-03-17 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
US20090054453A1 (en) * 2006-03-17 2009-02-26 Lilian Alcaraz Novel Tetralins as 5-HT6 Modulators
WO2008055945A1 (en) 2006-11-09 2008-05-15 Probiodrug Ag 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
WO2008065141A1 (en) 2006-11-30 2008-06-05 Probiodrug Ag Novel inhibitors of glutaminyl cyclase
ZA200905537B (en) 2007-03-01 2010-10-27 Probiodrug Ag New use of glutaminyl cyclase inhibitors
JP5667440B2 (ja) 2007-04-18 2015-02-12 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体
MX2012002993A (es) 2009-09-11 2012-04-19 Probiodrug Ag Derivados heterociclicos como inhibidores de ciclasa glutaminilo.
JP6026284B2 (ja) 2010-03-03 2016-11-16 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤
MX2012010470A (es) 2010-03-10 2012-10-09 Probiodrug Ag Inhibidores heterociclicos d ciclasa de glutaminilo (qc, ec .3 2. 5).
US8541596B2 (en) 2010-04-21 2013-09-24 Probiodrug Ag Inhibitors
WO2012123563A1 (en) 2011-03-16 2012-09-20 Probiodrug Ag Benz imidazole derivatives as inhibitors of glutaminyl cyclase
EP3461819B1 (de) 2017-09-29 2020-05-27 Probiodrug AG Hemmer der glutaminylcyclase
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer
CN110179988A (zh) * 2019-07-10 2019-08-30 王大伟 五羟色胺再摄取抑制剂和单胺氧化酶抑制剂联合在制备治疗抑郁症或早泄药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE204262T1 (de) * 1991-09-18 2001-09-15 Glaxo Group Ltd Benzanilidderivate als 5-ht1d-antagonisten
GB9119932D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
SE9601110D0 (sv) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives

Also Published As

Publication number Publication date
SK2832000A3 (en) 2000-09-12
DE69825062D1 (de) 2004-08-19
PT1014986E (pt) 2004-10-29
DE69825062T2 (de) 2005-08-25
SE9703376D0 (sv) 1997-09-18
EP1014986A1 (de) 2000-07-05
AR013503A1 (es) 2000-12-27
JP2001516719A (ja) 2001-10-02
NO20001400L (no) 2000-05-05
TR200000725T2 (tr) 2000-08-21
ID25789A (id) 2000-11-02
AU9193198A (en) 1999-04-05
IS5401A (is) 2000-03-14
ES2222603T3 (es) 2005-02-01
IL134775A0 (en) 2001-04-30
EP1014986B1 (de) 2004-07-14
CA2302204A1 (en) 1999-03-25
BR9812236A (pt) 2000-07-18
WO1999013878A1 (en) 1999-03-25
CN1278727A (zh) 2001-01-03
AU752719B2 (en) 2002-09-26
KR20010024084A (ko) 2001-03-26
DK1014986T3 (da) 2004-10-25
KR20010024087A (ko) 2001-03-26
HUP0100621A2 (hu) 2001-08-28
ATE270889T1 (de) 2004-07-15
US6159970A (en) 2000-12-12
PL339368A1 (en) 2000-12-18
ZA987804B (en) 1999-03-18
NO20001400D0 (no) 2000-03-17
MXPA00002616A (es) 2002-04-24

Similar Documents

Publication Publication Date Title
EE200000146A (et) Monoamiini oksüdaasi inhibiitori kombinatsioon h5-HT 1B antagonisti või osalise agonistiga
EE200000141A (et) 5-HT tagasihaarde inhibiitori kombinatsioon h5-HT 1B antagonisti või osalise agonistiga
ID19198A (id) Inhibitor metaloprotease heterosiklik
ID18416A (id) Inhibitor metaloprotease diheterosiklik
NO985828D0 (no) Viskoelastisk overflateaktivt stoff basert pÕ gelingssammensetning for service-fluider i borehull
ID27574A (id) Inhibitor enzim
EE9900030A (et) HPPD geen ja inhibiitorid
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
PT977737E (pt) Quino- e quinazolinas antagonistas de crf
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
NO20003256D0 (no) ACE inhibitor-MMP inhibitor kombinasjoner
PT927183E (pt) Inibidores espirociclicos de metaloproteases
DK0736525T3 (da) Benzonitriler som 5-HT-agonister og -antagonister
NO975073D0 (no) Lavtoksisk korrosjonshemmer
NO995545D0 (no) Korrosjonsinhibitor med lav toksisitet
ATE252547T1 (de) Matrixmetalloproteinaseinhibitoren
PT1194038E (pt) Composicao de quebra do repouso e sua utilizacao
DE69903319T2 (de) Fkbp inhibitoren
EE200000143A (et) Selektiivse 5-HT 1A antagonisti kombinatsioon selektiivse h5-HT 1B antagonisti või osalise agonistiga
DE69720957T2 (de) Ace-hemmer
NO20001176D0 (no) Anvendelse av blandinger av polymerer og aminoisothiasoler som biocider
DK1115389T3 (da) Fructosamin-oxidase: antagonister og inhibitorer
BR9700132A (pt) Composição contendo aditivos e coadjuvantes para a preservação de bebidas
SI1014985T1 (en) A combination of a 5-ht reuptake inhibitor and a h5-ht 1b antagonist or partial agonist